Mia Malan, founding editor-in-chief  and executive Director of the Bhekisisa Centre for Health Journalism talks to POWER Breakfast host Thabiso Tema on SAHPRA confirmed that it has registered drugmaker ViiV Healthcare’s HIV prevention jab. The World Health Organisation announced that CAB-LA is safe and a highly effective prevention option for people at substantial risk of HIV infection. According to a modelling study published in The Lancet HIV this month, that's 200 times more than what would be sensible for South Africa to pay.